http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990007807-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate | 1996-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19990007807-A |
| titleOfInvention | 3-phenyl-1,4-dialkyl-1,2,4-triazolium salt and its use as antidepressant |
| abstract | The present invention relates to a method of treating depression by administering the novel 3- (Rn-phenyl) -1,4-dialkyl-1,2,4-triazolium salt of formula (I).n n n Formula In n n n n n n n In the above formula,n n n R is halogen, trifluoromethyl, C 1-4 lower alkyl or C 1-4 lower alkoxy,n n n n is 0, 1 or 2,n n n R 1 and R 4 are independently C 1-3 lower alkyl,n n n A − is a pharmaceutically acceptable anion. |
| priorityDate | 1995-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.